ReShape Lifesciences (RSLS) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist

5.2900
+0.0500+0.95%

Close Nov 18 16:00 ET

3.77MMarket Cap-527P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Q3 2024 ReShape Lifesciences Inc Earnings Call
Yahoo FinanceNov 15 08:29 ET
ReShape Lifesciences Reports Q3 Growth and Strategic Moves
TipRanksNov 14 23:05 ET
ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 14 19:55 ET · Conference Call
ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsNov 14 19:43 ET
ReShape Lifesciences | 10-Q: Q3 2024 Earnings Report
SECNov 14 16:36 ET · Announcements
Express News | ReShape Lifesciences Q3 EPS $(3.11) Up From $(59.36) YoY; Revenue $2.292M Up From $2.155M YoY
BenzingaNov 14 16:30 ET

Comments

Jaguar8

Nov 14 19:49

Why on watchlist? Merger plus fair ER. Microfloat

$ReShape Lifesciences (RSLS.US)$

Jaguar8

Nov 14 19:32

NEWS ER

$ReShape Lifesciences (RSLS.US)$
ReShape Lifesciences (RSLS) reported Q3 2024 financial results, showing revenue growth of 16.6% over Q2 2024 and 6.4% year-over-year to $2.3 million.
The company achieved a 40.6% reduction in operating expenses for the first nine months of 2024 compared to 2023.
Gross profit margin improved to 62.8% in Q3 2024.
The company entered into a merger agreement with Vyome Therapeutics and an asset purchase agreement with Biorad Medisys for $5.16 million.
ReSha...

Trytosaveabit

Nov 14 15:08

News

$ReShape Lifesciences (RSLS.US)$ Reuters· just
ReShape Lifesciences: Entered Into Merger Agreement With Vyome Therapeutics & Asset Purchase Agreement With Biorad Medisys

Trytosaveabit

Nov 12 07:36

News

$ReShape Lifesciences (RSLS.US)$ Reuters
4 mins ago
ReShape Lifesciences® Receives Health Canada Approval for Its Next-Generation Lap-Band® 2.0 Flex

Jaguar8

Nov 12 07:32

NEWS

$ReShape Lifesciences (RSLS.US)$
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
ReShape Lifesciences (Nasdaq: RSLS) has received Health Canada approval for its next-generation Lap-Band® 2.0 FLEX and Tubing Kit. The enhanced device features new Flex technology that acts as a relief valve, allowing larger food pieces to pass through more easily by temporarily relaxing before returning to its resting diameter. Like its predecessor, the device can...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

RSLS ReShape Lifesciences

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target